We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KLAC:NASDAQKLA Corporation Analysis

Data as of 2026-03-09 - not real-time

$1,429.10

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

KLA Corporation is trading at $1,429, comfortably above its 20‑day SMA of $1,471 and the 50‑day SMA of $1,440, while still remaining under the 200‑day SMA of $1,115, indicating a bullish medium‑term trajectory. The stock sits on a solid support zone around $1,321 and faces resistance near $1,577, with a calculated upside of roughly 16.6% toward the median analyst target of $1,700. Technical momentum is mixed: the MACD line is deep in bearish territory (-1.81) and the histogram is negative, yet the RSI at 47.5 suggests the price is not yet oversold. Volatility is elevated at over 70% on a 30‑day basis and beta exceeds 1.8, flagging heightened price swings relative to the market. Fundamentals show strong profitability—gross margin over 61% and operating margin above 41%—but valuation metrics are stretched, with a PE of 41.7 versus the industry average of 36.8 and a price‑to‑book of 34.3. The DCF fair‑value estimate of $455 is far below the current price, reinforcing the overvaluation view. Recent headlines add a layer of uncertainty: a 15% post‑earnings drop and a downgrade to “sell” cite margin pressure and China exposure, while a “positive catalyst watch” ahead of the upcoming Investor Day and a Citi upgrade to “buy” highlight potential upside. The dividend is modest at 0.57% with a payout ratio of 21%, supported by robust cash flow and a comfortable debt‑to‑equity profile. In this context, the stock offers a short‑term entry point on the dip but remains pricey for growth‑focused investors, making a nuanced hold‑or‑buy stance advisable.
Overall, KLA’s strong operating fundamentals and sector leadership provide a solid long‑term platform, yet the current valuation premium and heightened volatility suggest caution, especially for investors sensitive to macro‑cycle and geopolitical risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent 15% earnings‑driven price drop creates a near‑term support test
  • Bearish MACD and negative histogram signal short‑term downside pressure
  • Valuation remains far above DCF fair value, limiting upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Price above 20‑day and 50‑day SMAs with bullish trend direction
  • Upside potential of ~16% toward analyst median target
  • Positive catalyst watch ahead of Investor Day and recent Citi upgrade

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustained high margins and strong cash generation support dividend sustainability
  • Industry leadership in advanced semiconductor process control
  • Elevated valuation premium and cyclicality of semiconductor equipment demand

Key Metrics & Analysis

Financial Health

Revenue Growth7.20%
Profit Margin35.76%
P/E Ratio41.7
ROE100.73%
ROA21.09%
Debt/Equity111.78
P/B Ratio34.3
Op. Cash Flow$4.8B
Free Cash Flow$3.2B
Industry P/E36.8

Technical Analysis

TrendBullish
RSI47.5
Support$1,321.02
Resistance$1,577.35
MA 20$1,471.35
MA 50$1,439.83
MA 200$1,114.73
MACDBearish
VolumeStable
Fear & Greed Index100

Valuation

Fair Value$454.86
Target Price$1,666.70
Upside/Downside16.63%
GradeOvervalued
TypeGrowth
Dividend Yield0.57%

Risk Assessment

Beta1.80
Volatility70.45%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.